Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recaticimab and Statin in Asymptomatic Intracranial Atherosclerosis
NCT06902740Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Nov 2025
- Primary completion
- Dec 2027
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of recaticimab in intracranial atherosclerosis (ICAD), sponsored by Peking Union Medical College Hospital. Started Nov 2025; status: recruiting.
02
Drugs
recaticimab
03
Conditions
intracranial atherosclerosis (ICAD)
Beyond the preview
Go deeper on NCT06902740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06902740.